Compositions and methods for reducing neointima formation
AssigneeUniversity of Georgia Research Foundation, Inc.
InventorsShiyou Chen, Rui Tang
Life of this patent
Estimating the term…
Abstract
Compositions, devices, grafts and methods for reducing or preventing anti-neointima following cardiovascular injuries and interventions are disclosed. The compositions, devices, and grafts typically include an effective amount of a CTP synthase 1 inhibitor to reduce proliferation of vascular smooth muscle cells, without substantial reducing the proliferation of endothelial cells. Methods of reducing neointima formation, accelerating re-endothelialization, and reducing restenosis in a subject using the compositions, devices, and grafts are also disclosed.
Claims20
A method of reducing proliferation of vascular smooth muscle cells or reducing neointima formation in a subject comprising implanting into the subject a medical device comprising an effective amount of a CTP synthase 1 (CTPS1) inhibitor to reduce proliferation of vascular smooth muscle cells (VSMC) in the subject to a greater degree than the inhibitor reduces endothelial cell proliferation in the subject,
- wherein the CTPS1 inhibitor is a nucleoside analog.
A method of reducing proliferation of vascular smooth muscle cells or reducing neointima formation in a subject comprising implanting into the subject a medical device comprising an effective amount of cyclopentenyl cytosine (CPEC)
- to reduce proliferation of vascular smooth muscle cells (VSMC) in the subject to a greater degree than the CPEC reduces endothelial cell proliferation in the subject.
Dependencies are inferred from the claim text.